SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-135337
Filing Date
2024-05-09
Accepted
2024-05-09 16:50:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d823033ds3.htm S-3 430872
2 EX-1.2 d823033dex12.htm EX-1.2 190355
3 EX-4.4 d823033dex44.htm EX-4.4 279128
4 EX-5.1 d823033dex51.htm EX-5.1 16749
5 EX-5.2 d823033dex52.htm EX-5.2 9992
6 EX-23.1 d823033dex231.htm EX-23.1 1859
7 EX-FILING FEES d823033dexfilingfees.htm EX-FILING FEES 52770
8 GRAPHIC g823033g00a04.jpg GRAPHIC 605282
9 GRAPHIC g823033g00a40.jpg GRAPHIC 608065
10 GRAPHIC g823033g00a64.jpg GRAPHIC 37100
11 GRAPHIC g823033g0507073315005.jpg GRAPHIC 2668
  Complete submission text file 0001193125-24-135337.txt   2687356
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279275 | Film No.: 24931555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)